Kindly read this image, analyze carefully and find a clinical features, Diagnostic workup, Management ( with dose or unit and Complications ( with discharge or follow up)
Reading File
Based on the three images provided, here is a comprehensive structured analysis of Migraine and Headache in Children:
MIGRAINE & HEADACHE IN CHILDREN
(Source: Nelson Textbook of Pediatrics 21st ed.; Child Neurology 7th ed.; IHS Classification 2013)
I. CLINICAL FEATURES
A. Common Causes of Headache
| Type | Causes |
|---|---|
| Primary Headache | Tension-type headache, Migraine headache, Trigeminal autonomic cephalalgias, Other primary headache disorders |
| Secondary Headache (underlying cause) | Trauma/injury, Cranial or cervical vascular disorder, Nonvascular intracranial disorder, Substance abuse/withdrawal, Infection, Disorders of homeostasis, Facial/cervical structures, Psychiatric disorders, Neuropathies/facial pains |
B. Migraine vs. Tension-Type Headache (TTH) — Comparison
| Feature | Tension-Type Headache (TTH) | Migraine Headache |
|---|---|---|
| Severity | Mild to moderate | Moderate to severe |
| Location | Diffuse | Focal; usually unilateral (in children may be bilateral/bifrontal) |
| Character | Non-throbbing | Throbbing or pounding |
| Aura | Not frequently present; symptoms like nausea, photophobia, phonophobia, vomiting never occur together | May or may not be present; Typical: visual/sensory/dysphasic; Atypical: hemiplegic/Alice in Wonderland syndrome |
| Nausea/Vomiting | Uncommon | Frequent |
| Effect of Activity | Not affected | Usually exacerbated |
C. Migraine Manifestations
Episodic attacks of moderate-to-severe intensity, focal location, throbbing quality; may be associated with nausea, vomiting, photophobia, phonophobia.
Types of Migraine:
| Type | Key Features |
|---|---|
| Migraine Without Aura | Most prevalent; throbbing/pounding; bifrontal or temporal; intense nausea/vomiting; family history in 90% (maternal); light-headedness, photophobia, osmophobia, phonophobia |
| Typical Aura | Visual/sensory/dysphasic |
| Atypical Aura | Hemiplegic/Alice in Wonderland syndrome |
| Cyclic Vomiting | Recurrent severe vomiting (5x/hour) in infants; persists 1–5 days; complete resolution between attacks; child resumes normal play after deep sleep |
| Abdominal Migraine | Mid-abdominal pain with pain-free periods; ≥2 of: anorexia, nausea, vomiting, pallor; pain lasts 1–72 hours |
| Hemiplegic Aura | Unilateral sensory or motor signs persisting for days; good prognosis in older child/adolescent |
| Basilar-type Migraine | Vasoconstriction of basilar and posterior cerebral arteries; vertigo, tinnitus, diplopia, scotoma, ataxia, altered consciousness, seizures; complete resolution after attack; girls <4 years at risk |
D. Red Flags — SNOOPY Acronym
| Letter | Red Flag |
|---|---|
| S | Systemic signs: fever, weight loss, rash, meningeal signs, neurocutaneous lesions, malignancy |
| N | Neurologic signs: hemiparesis, papilledema, hemisensory loss, diplopia, visual changes, dysarthria, seizures, ataxia, cognitive change, head injury history |
| O | Onset: sudden "worst headache of life" (thunderclap), explosive onset; early morning or awakening with headache |
| O | Occipital: location of the headache |
| P | P5: Progression of existing headache; previous headache history; precipitated by Valsalva, postural, pregnancy; change in quality/frequency/location; steadily worsening pattern |
| Y | Younger: age group of patients |
E. Etiopathogenesis
- More common in females during adolescence
- More common in males <10 years old
-
50% undergo spontaneous prolonged remission after the 10th birthday
- No single theory explains the exact pathogenesis
II. DIAGNOSTIC WORKUP
A. Indications for Neuroimaging
(Imaging of choice: Cranial MRI)
- Abnormal neurologic examination
- Abnormal or focal neurologic signs/symptoms
- Seizures or very brief auras (<5 mins)
- Unusual headaches:
- Atypical auras: basilar-type, hemiplegic
- Trigeminal autonomic cephalalgia including cluster headaches
- Acute secondary headache
- Brief cough headache
- Headache worse upon awakening or awakens child from sleep
- Migrainous headache in a child with no family history of migraine
B. Functional/Disability Assessment
- PedMIDAS (Pediatric Migraine Disability Assessment) — self-administered questionnaire assessing migraine disability in pediatric and adolescent patients
III. MANAGEMENT
A. Three Core Components
- Acute treatment — stops the headache attack; goal: return to function within 2 hours maximum
- Preventive treatment — when headaches are frequent (≥1 per week) and disabling
- Biobehavioral therapy
B. Acute Treatment Algorithm
- Mild to moderate: Start with NSAIDs; restrict to no more than 2–3 attacks/week
- Moderate to severe OR NSAID failure: Add Triptans
- Restrict to ≤4–6 attacks/month
- NSAIDs can be repeated q3–4hr; Triptans q2hr
- Fluid hydration — essential (vascular dilation is a common migraine feature)
- Status migrainosus (persistent headache >3 days) → Refer to specialist
C. Pharmacologic Options (with Doses)
1. NSAIDs
(Not more than 2–3 times/week to avoid medication overuse headache)
| Drug | Dose |
|---|---|
| Paracetamol | 15 mg/kg/dose q4–6h (max 90 mg/kg/24h) |
| Ibuprofen | 7.5 mg/kg/dose q6–8h (max 40 mg/kg/24h) |
| Aspirin | Alternative for patients >15 years old |
2. Triptans
(For migraines uncontrolled by NSAIDs)
| Drug | Notes |
|---|---|
| Almotriptan | Side effects: tightness of jaw, chest, fingers (vascular constriction); grogginess and fatigue (central serotonin effect) |
| Rizatriptan | Same class side effects as above |
3. Antiemetics
(Dopaminergic antagonists; used if severe and unresponsive to NSAIDs and Triptans)
| Drug | Notes |
|---|---|
| Prochlorperazine | Dopamine antagonism |
| Metoclopramide | Dopamine antagonism |
D. Preventive Therapy
Indications:
- Frequent: >1x/week
-
1 disabling headache/month
- Missing school, home, or social activities
- Contraindications to or overuse of acute therapy
- Uncommon conditions: hemiplegic migraine, basilar migraine, prolonged aura
- PedMIDAS score >20
Goals:
- Reduce frequency to 1–2 or fewer per month
- Reduce disability: PedMIDAS <10
Preventive Drugs (with Doses):
| Drug | Dose & Remarks |
|---|---|
| Flunarizine | 5 mg OD, increased after 10 months to 10 mg OD; with a 1-month drug holiday every 4–6 months; only agent demonstrating clear level of effectiveness |
| Amitriptyline | 1 mg/kg/day daily; Side effects: sleepiness, anticholinergic activity |
| Topiramate | 50 mg BID (adults/adolescents); dose must be reached slowly (titrated) |
| Others | Valproic acid, Beta-blockers |
IV. COMPLICATIONS, DISCHARGE & FOLLOW-UP
A. Complications
| Complication | Details |
|---|---|
| Medication Overuse Headache (MOH) | NSAIDs used >2–3x/week; Triptans used >4–6x/month can rebound and worsen headache pattern |
| Status Migrainosus | Persistent headache lasting >3 days — requires specialist referral |
| Triptans Side Effects | Vascular constriction → tightness of jaw, chest, fingers; CNS effects → grogginess, fatigue |
| Amitriptyline Side Effects | Sedation, anticholinergic effects (dry mouth, urinary retention, constipation) |
| Basilar-Type Migraine | Risk of altered consciousness and seizures; especially in girls <4 years |
| Hemiplegic Migraine | Unilateral motor/sensory deficits that may persist for days |
| Disability | Academic impairment, missed school/social activities — measured by PedMIDAS |
B. Discharge Criteria
- Headache controlled with acute medications
- Adequate oral hydration maintained
- No red flag (SNOOPY) signs present
- Patient/caregiver educated on:
- Trigger avoidance
- Proper medication use (dose limits, frequency)
- When to return to ED (status migrainosus, new neurologic deficits, thunderclap headache)
C. Follow-Up Plan
| Situation | Action |
|---|---|
| Frequent migraines (≥1/week) | Initiate preventive therapy; follow up in 4–6 weeks |
| PedMIDAS score >20 | Start preventive agents; reassess disability score at follow-up |
| On Flunarizine | Review at 10 months for dose adjustment; schedule 1-month holiday every 4–6 months |
| On Topiramate | Ensure slow titration; monitor for cognitive side effects |
| Status migrainosus | Refer to pediatric neurology specialist |
| Abnormal neuroimaging indications met | Order cranial MRI before or at follow-up |
| All migraine patients | PedMIDAS reassessment; trigger diary review; biobehavioral therapy reinforcement |
Sources: Kliegman R, et al. Nelson Textbook of Pediatrics (21st ed.), Elsevier, 2020 | Menkes J, et al. Child Neurology (7th ed.), Lippincott Williams & Wilkins, 2006 | Dooley J, et al. Paediatrics & Child Health, 2009 | IHS Headache Classification Committee, 2013
Make it sperately for Migraine headache (Clinical features, Diagnostic workup, Management and Complications) or Tension type of headache (Clinical features, Diagnostic workup, Management and Complications) make sure you will use only image information, not any other sources and make it in short elaborated sentences key points points, which is suitable to put in PowerPoint slide
Reading File
Below is the PowerPoint-ready content, strictly based on the image information only, split into two separate sections.
🧠 MIGRAINE HEADACHE
📋 CLINICAL FEATURES
Epidemiology
- More common in females during adolescence
- More common in males <10 years old
-
50% undergo spontaneous remission after the 10th birthday
Pain Characteristics
- Severity: Moderate to severe
- Location: Focal; usually unilateral — in children may be bilateral (bifrontal)
- Character: Throbbing or pounding
- Activity: Usually exacerbated by physical activity
Associated Symptoms
- Nausea and vomiting — frequent
- Photophobia, phonophobia, osmophobia
- Light-headedness
Aura
- May or may not be present
- Typical aura: Visual / sensory / dysphasic
- Atypical aura: Hemiplegic / Alice in Wonderland syndrome
Types of Migraine
| Type | Key Features |
|---|---|
| Without Aura | Most prevalent; throbbing; bifrontal/temporal; intense nausea/vomiting; family history in 90% (maternal) |
| Cyclic Vomiting | Recurrent severe vomiting (5x/hour) in infants; lasts 1–5 days; complete resolution between attacks |
| Abdominal Migraine | Mid-abdominal pain + ≥2 of: anorexia, nausea, vomiting, pallor; pain lasts 1–72 hours |
| Hemiplegic Aura | Unilateral sensory/motor signs persisting for days; good prognosis in older child/adolescent |
| Basilar-type | Vertigo, tinnitus, diplopia, scotoma, ataxia, altered consciousness, seizures; complete resolution after attack; girls <4 years at risk |
🔍 DIAGNOSTIC WORKUP
Imaging of Choice: Cranial MRI
Indications for Neuroimaging:
- Abnormal neurologic examination
- Abnormal or focal neurologic signs/symptoms
- Seizures or very brief auras (< 5 mins)
- Atypical auras: basilar-type, hemiplegic
- Headache worse upon awakening or awakens child from sleep
- Migrainous headache with no family history of migraine
Disability Assessment:
- PedMIDAS (Pediatric Migraine Disability Assessment)
- Self-administered questionnaire
- Assesses migraine disability in pediatric & adolescent patients
- Score >20 → indicates need for preventive therapy
Red Flags — SNOOPY:
- S — Systemic signs: fever, weight loss, rash, meningeal signs
- N — Neurologic signs: hemiparesis, papilledema, seizures, ataxia
- O — Onset: thunderclap / "worst headache of life"
- O — Occipital location
- P — Progression / worsening pattern / Valsalva-precipitated
- Y — Younger age group
💊 MANAGEMENT
Three Core Components:
- Acute treatment — stops attack; goal: return to function within 2 hours
- Preventive treatment — when ≥1 headache/week and disabling
- Biobehavioral therapy
Acute Treatment:
- Mild–Moderate → NSAIDs (restrict to ≤2–3 attacks/week)
- Moderate–Severe or NSAID failure → Add Triptans
- Restrict total attacks treated to ≤4–6/month
- NSAIDs repeat: q3–4hr | Triptans repeat: q2hr
- Fluid hydration — essential (vascular dilation is a core feature)
- Status migrainosus (>3 days) → Refer to specialist
Pharmacologic Options:
| Class | Drug | Dose |
|---|---|---|
| NSAIDs | Paracetamol | 15 mg/kg/dose q4–6h (max 90 mg/kg/24h) |
| Ibuprofen | 7.5 mg/kg/dose q6–8h (max 40 mg/kg/24h) | |
| Aspirin | Alternative for >15 years only | |
| Triptans | Almotriptan / Rizatriptan | For NSAIDs-uncontrolled migraine |
| Antiemetics | Prochlorperazine / Metoclopramide | If severe and unresponsive to NSAIDs + Triptans |
Preventive Therapy — Indications:
- Frequency: >1x/week
-
1 disabling headache/month
- Missing school/social activities
- Contraindication to or overuse of acute therapy
- Uncommon types: hemiplegic, basilar, prolonged aura
- PedMIDAS score >20
Preventive Therapy — Drugs & Doses:
| Drug | Dose | Notes |
|---|---|---|
| Flunarizine | 5 mg OD → 10 mg OD after 10 months | 1-month holiday every 4–6 months; only drug with proven effectiveness |
| Amitriptyline | 1 mg/kg/day | SE: sleepiness, anticholinergic effects |
| Topiramate | 50 mg BID (adults/adolescents) | Dose reached slowly (titrated) |
| Others | Valproic acid, Beta-blockers | — |
Goals of Preventive Therapy:
- Reduce frequency to 1–2 episodes/month or fewer
- Reduce disability: PedMIDAS <10
⚠️ COMPLICATIONS & FOLLOW-UP
Complications:
- Medication Overuse Headache — NSAIDs >2–3x/week or Triptans >4–6x/month
- Status Migrainosus — persistent headache >3 days → specialist referral
- Triptans SE — jaw/chest/finger tightness (vascular constriction); grogginess, fatigue
- Amitriptyline SE — sleepiness, anticholinergic activity
- Basilar-type — risk of altered consciousness and seizures
- Academic/social disability — tracked via PedMIDAS score
Discharge:
- Headache controlled; adequate oral hydration
- No SNOOPY red flags present
- Patient/caregiver educated on trigger avoidance and medication limits
Follow-Up:
- Frequent migraines (≥1/week) → Start preventive therapy; review in 4–6 weeks
- PedMIDAS >20 → Start preventive agents; reassess score at next visit
- On Flunarizine → Review at 10 months for dose adjustment
- Status migrainosus → Refer to pediatric neurology
- All patients → PedMIDAS reassessment + trigger diary review
📌 TENSION-TYPE HEADACHE (TTH)
📋 CLINICAL FEATURES
Pain Characteristics:
- Severity: Mild to moderate
- Location: Diffuse
- Character: Non-throbbing
- Activity: Not affected by physical activity
Associated Symptoms:
- Nausea, photophobia, phonophobia, vomiting — do NOT occur together at the same time
- Aura: Not frequently associated
Key Distinguishing Points:
- Symptoms like nausea, photophobia, phonophobia may appear individually but never simultaneously
- No throbbing quality — pressure/tightening sensation
🔍 DIAGNOSTIC WORKUP
Imaging of Choice: Cranial MRI (if red flags present)
Indications for Neuroimaging (same SNOOPY criteria apply):
- Abnormal neurologic examination
- Focal neurologic signs
- Seizures or very brief auras (<5 mins)
- Headache awakening child from sleep
- Sudden "worst headache of life"
- Occipital location
- Progressively worsening pattern
- Younger age group with no family history
Red Flags — SNOOPY:
- S — Systemic: fever, weight loss, rash, meningeal signs, malignancy
- N — Neurologic: hemiparesis, papilledema, diplopia, ataxia, seizures
- O — Onset: thunderclap / early morning awakening headache
- O — Occipital location
- P — Progression / Valsalva / postural changes / worsening pattern
- Y — Younger age patients
💊 MANAGEMENT
(Based on image information — TTH management follows the same acute pharmacologic approach as outlined for primary headaches)
Acute Treatment:
- NSAIDs for mild-to-moderate headache
- Paracetamol: 15 mg/kg/dose q4–6h (max 90 mg/kg/24h)
- Ibuprofen: 7.5 mg/kg/dose q6–8h (max 40 mg/kg/24h)
- Aspirin: alternative for >15 years only
- Restrict NSAID use to ≤2–3 times/week to avoid medication overuse headache
- NSAIDs can be repeated q3–4hr
- Fluid hydration — supportive measure
- Biobehavioral therapy — component of management
(Note: Triptans are NOT indicated for TTH — they are reserved for migraine only)
⚠️ COMPLICATIONS & FOLLOW-UP
Complications:
- Medication Overuse Headache (MOH) — NSAIDs used >2–3x/week can rebound and worsen headache pattern
- Risk of chronic daily headache if medications overused
- Associated with psychiatric disorders (anxiety, depression) as an underlying secondary cause
Discharge:
- Headache controlled with NSAIDs
- No red flag (SNOOPY) signs present
- Patient/caregiver educated on:
- Medication frequency limits
- Trigger identification and avoidance
- When to return: new neurologic signs, sudden severe headache, worsening pattern
Follow-Up:
- Review headache diary and trigger patterns
- Reassess if headache frequency increases or character changes
- Escalate workup (cranial MRI) if any SNOOPY red flags develop
- Biobehavioral therapy reinforcement at each visit
Source: Kliegman R, et al. Nelson Textbook of Pediatrics (21st ed.), Elsevier, 2020 | Menkes J, et al. Child Neurology (7th ed.), 2006 | IHS Classification, 2013 | Dooley J, et al. Paediatrics & Child Health, 2009
This is a shared conversation. Sign in to Orris to start your own chat.